Lv1
80 积分 2025-03-04 加入
hERG Inhibitors with Similar Potency But Different Binding Kinetics Do Not Pose the Same Proarrhythmic Risk: Implications for Drug Safety Assessment
11天前
已完结
Schalm's Veterinary Hematology
16天前
已完结
Protein Kinase Inhibitors in Heart Failure: Mechanistic Insights and Therapeutic Prospects
27天前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
1个月前
已完结
Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species
2个月前
已完结
Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility
2个月前
已完结
Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve
2个月前
已完结
Historical Control Data of Spontaneous Tumors in Transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) Mice
2个月前
已完结
Historical Background Data in CB6F1-Tg-rasH2 Mice and CB6F1-nonTg-rasH2 Mice over a 26-Week Experimental Period
2个月前
已完结
Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment
2个月前
已完结
皖公网安备34019202002308
